Technische Universität Dresden
Clinical trials sponsored by Technische Universität Dresden, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- AI learns from thousands of ICU patients to improve ventilator care Results expected Sep 2026 (estimated)
- Can a simple blood test after pancreatic surgery save lives? Results expected Dec 2026 (estimated)
- AI co-pilot for robot surgery tested in rectal cancer patients Results expected Jan 2027 (estimated)
- Lung cancer immune markers under the microscope Results expected Mar 2027 (estimated)
- New drug cocktail aims to beat back a tough leukemia Results expected Apr 2027 (estimated)
-
Can a Three-Drug combo outsmart returning leukemia?
Disease control CompletedThis trial tests whether adding venetoclax to a standard chemotherapy pair (cytarabine and mitoxantrone) can help adults with acute myeloid leukemia that has relapsed or not responded to initial treatment. In the first phase, researchers find the highest safe dose of cytarabine w…
Phase 1/2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Smartphone sensors may predict bipolar mood swings before they strike
Disease control CompletedThis trial tests whether continuous smartphone monitoring can detect early warning signs of depression or mania in people with bipolar disorder. Participants use an app that tracks activity and location, and some receive personalized alerts from their doctor when the app detects …
Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can proton beams spare prostate cancer patients from side effects?
Disease control CompletedThis trial compares two types of radiation therapy for prostate cancer: proton therapy and standard photon therapy. The main question is whether proton therapy reduces moderate to severe urinary or intestinal side effects. Researchers will also track quality of life, cancer recur…
Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo shows promise for High-Risk leukemia patients
Disease control CompletedThis study tested a new treatment for adults with a high-risk form of acute promyelocytic leukemia (APL). The experimental therapy combined arsenic trioxide, ATRA, and a low dose of idarubicin, aiming to improve survival and reduce side effects compared to the standard chemothera…
Phase 3 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Lung surgery ventilation showdown: high vs low pressure in 2,200 patients
Knowledge-focused CompletedThis study looked at 2,200 adults having lung surgery where one lung is deflated during the procedure. Doctors tested two ways of using the breathing machine: one with higher pressure and periodic deep breaths, the other with lower pressure and no deep breaths. The goal was to se…
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC